Zymergen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 507

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Zymergen General Information

Description

Developer of microbe-based diversified inputs and technology intended for agricultural and industrial applications. The company specializes in designing, developing, and manufacturing bio-based breakthrough products that deliver value to customers in a broad range of industries with a combination of biology, chemistry, software, and automation, helping companies to design and create new materials.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Commercial Products
Other Materials
Other Agriculture
Corporate Office
  • 5959 Horton Street
  • Floor 7
  • Emeryville, CA 94608
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymergen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Bankruptcy: Admin/Reorg 03-Oct-2023 Completed Bankruptcy: Admin/Reorg
12. Merger/Acquisition 19-Oct-2022 00000 00.000 00000 Completed Generating Revenue
11. IPO 22-Apr-2021 00000 00.000 00.000 Completed Generating Revenue
10. Later Stage VC (Series D) 29-Jul-2020 00000 00.000 00.000 Completed Generating Revenue
9. Debt - General 01-Jan-2019 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series C) 13-Dec-2018 00000 00000 00000 Completed Generating Revenue
7. Secondary Transaction - Private 29-Nov-2017 00000 Completed Generating Revenue
6. Early Stage VC (Series B) 29-Nov-2017 000.00 00000 00000 Completed Generating Revenue
5. Early Stage VC (Series B) 07-Oct-2016 $130M $174M 00000 Completed Generating Revenue
4. Early Stage VC (Series A) 04-Jun-2015 $36.6M $43.6M 000.00 Completed Generating Revenue
To view Zymergen’s complete valuation and funding history, request access »

Zymergen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 26,158,833 $0.001000 $0.02 $0.25 $0.25 1x $0.25 9.5%
Series A 21,998,250 $0.001000 $0.13 $1.66 $1.66 1x $1.66 7.99%
To view Zymergen’s complete cap table history, request access »

Zymergen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbe-based diversified inputs and technology intended for agricultural and industrial applications. The
Biotechnology
Emeryville, CA
507 As of 2021
00.000
0000000000.

000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000000000000
Roslin, United Kingdom
00 As of 0000
0000000000

000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000000000000
Gainesville, FL
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zymergen Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ingenza Corporation Roslin, United Kingdom 00 0000000000
BioTork Venture Capital-Backed Gainesville, FL 0 000.00 0000000000 0 000.00
Twist Bioscience Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
Arzeda Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
To view Zymergen’s complete competitors history, request access »

Zymergen Executive Team (21)

Name Title Board Seat Contact Info
Zach Serber Ph.D Co-Founder & Board Member
You’re viewing 1 of 21 executive team members. Get the full list »

Zymergen Board Members (10)

Name Representing Role Since
Rohit Sharma Ph.D True Ventures Board Member 000 0000
Sandra Peterson Self Board Member 000 0000
Zach Serber Ph.D Zymergen Co-Founder & Board Member 000 0000
You’re viewing 3 of 10 board members. Get the full list »

Zymergen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymergen Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lodo Therapeutics 16-May-2021 0000000000 000.00 Drug Discovery
enEvolv 19-Mar-2020 0000000000 000.00 Biotechnology 000000 00
Radiant Genomics 08-Jan-2018 Merger/Acquisition Other Commercial Services 000000 00
To view Zymergen’s complete acquisitions history, request access »

Zymergen FAQs

  • When was Zymergen founded?

    Zymergen was founded in 2013.

  • Who is the founder of Zymergen?

    Joshua Hoffman, Jed Dean Ph.D, and Zach Serber Ph.D are the founders of Zymergen.

  • Where is Zymergen headquartered?

    Zymergen is headquartered in Emeryville, CA.

  • What is the size of Zymergen?

    Zymergen has 507 total employees.

  • What industry is Zymergen in?

    Zymergen’s primary industry is Biotechnology.

  • Is Zymergen a private or public company?

    Zymergen is a Private company.

  • What is Zymergen’s current revenue?

    The current revenue for Zymergen is 00000.

  • How much funding has Zymergen raised over time?

    Zymergen has raised $1.58B.

  • Who are Zymergen’s competitors?

    Ingenza, BioTork, Twist Bioscience, and Arzeda are competitors of Zymergen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »